Trademark Search  /  REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION

REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION

○ Dead · Abandoned

U.S. federal trademark · Serial No. 85041166

Mark
REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION
Status
Abandoned
Serial Number
85041166
Filing Date
May 18, 2010
Class(es)
Class 042

Owners

Bristol-Myers Squibb Company
03 · New York, NY, US
Bristol-Myers Squibb Company
03 · New York, NY, US

Goods & Services

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.